Pranoot Tanpaiboon

Quest Diagnostics (United States)

Papers

1

Total Citations

26

H-Index

1

About

Pranoot Tanpaiboon is a clinical researcher whose work centers on viral genomics and infectious disease diagnostics, with a particular focus on SARS-CoV-2 surveillance. Her most impactful contribution to date is the development and validation of a high-throughput SARS-CoV-2 whole genome sequencing workflow for clinical laboratories, published in 2022 and cited 26 times. This work addressed a critical need during the COVID-19 pandemic: enabling rapid, scalable monitoring of emerging viral mutations. By optimizing next-generation sequencing protocols for clinical settings, Tanpaiboon’s workflow provided essential data for identifying diagnostic and therapeutic targets, as well as informing public health strategies for outbreak control. Her research bridges the gap between advanced genomic technologies and practical clinical application, demonstrating how NGS can be effectively deployed for real-time pathogen surveillance. This achievement highlights her role in strengthening pandemic preparedness and underscores the importance of genomic epidemiology in combating infectious diseases. Tanpaiboon’s work continues to support efforts to track viral evolution and improve response strategies for current and future health threats.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago